Wisconsin AB 747: Relating to: creating a Prescription Drug Affordability Review Board, funding for an office of prescription drug affordability, crediting certain amounts to the general program operations account of the office of the commissioner of insurance, granting rulemaking authority, and making an appropriation. (FE)

Status: Failed to pass pursuant to Senate Joint Resolution 1 (as of 2024-04-15)

State: Wisconsin · Session: 2023 · Bill: AB 747

Sponsors: Andraca, Bare, Billings, C. Anderson, Clancy, Conley, Considine, Drake, Emerson, Haywood, Hong, J. Anderson, Jacobson, Joers, Madison, Moore Omokunde, Neubauer, Ortiz-Velez, Palmeri, Ratcliff, Shankland, Shelton, Sinicki, Subeck

View Wisconsin AB 747 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.